MRI Morphology of Femoral Notch in ACL Injury
Launched by ASSIUT UNIVERSITY · Nov 24, 2024
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the relationship between the shape of a specific area in the knee, called the femoral notch, and the risk of injuring the anterior cruciate ligament (ACL). The study will use MRI scans to see if certain shapes of the femoral notch might make someone more likely to have an ACL injury. The trial is not yet recruiting participants, but they are looking for individuals aged 18 to 50 who have been diagnosed with an ACL injury confirmed by an MRI. They will also include healthy volunteers who are similar in age but do not have an ACL injury.
If you are eligible to participate, you can expect to undergo an MRI scan to evaluate your knee. It’s important to note that individuals younger than 18, older than 50, those who have had previous knee surgeries, have certain knee deformities, or have medical conditions affecting bone health will not be included in the study. This research could help doctors understand ACL injuries better and potentially lead to new ways to prevent them in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patient aged 18-50 years.
- • diagnosed with an ACL injury and confirmed by MRI and age-matched controls.
- Exclusion Criteria:
- • age \<18 yo and \>50 years
- • patients with previous knee surgeries
- • congenital knee deformities
- • systemic conditions affecting bone health
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported